PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTION

The Lancet

Volumn 334, Issue 8671, 1989, Pages 1057-1062

  Wakefield, A J ^a   Dhillon, A P ^a   Rowles, P M ^b   Sawyerr, A M ^a   Pittilo, R M ^b   Lewis, A A M ^a   Pounder, R E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ARTICLE; CROHN DISEASE; HISTOLOGY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL;

CECUM; COLON; CROHN DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ILEUM; INFARCTION; INTESTINES; MALE; MICROSCOPY, ELECTRON, SCANNING; VASCULITIS;

EID: 0024445939     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)91078-7     Document Type: Article

References (48)

1. Extraintestinal manifestations of inflammatory bowel disease
2. Primary secondary and coincidental ocular complications of Crohn's disease
3. Association of inflammatory bowel disease and large vascular lesions
4. Vascular changes in Crohn's disease
5. Arterial inflammatory infiltration in Crohn's disease
6. Saggital sinus thrombosis as a complication of regional enteritis
7. Thrombosis in inflammatory bowel disease
8. Vascular complications of inflammatory bowel disease
9. Study of certain microscopic features in regional enteritis, and their possible prognostic significance.
10. Cytokine-mediated activation of the vascular endothelium
11. Activation of blood coagulation in Crohn's disease
12. Endothelium—the axis of vascular health and disease
13. Microcirculatory changes in the livers of mice infected with murine hepatitis virus. Evidence from microcorrosion casts and measurements of red cell velocity
14. The vasculitis syndromes in small and medium-sized vessels
15. The chronological sequence in the pathway of Crohn's disease
16. Role of ischaemia in the initiation of peptic ulcer
17. The arthus phenomenon in the colon of rabbits: a serial histological study
18. The Schwartzman phenomenon in the colon of rabbits. serial histological study
19. Ischaemia of the gut
20. Complications of the surgical treatment of ulcerative colitis and Crohn's disease
21. Diverting ileostomy or colostomy in the management of Crohn's disease of the colon
22. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis A 20 year survey
23. Physiology and pathophysiology of the colonic circulation
24. The epidemiology of idiopathic inflammatory bowel disease
25. Enhanced thrombin generation and platelet binding on Herpes simplex virus-induced endothelium
26. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection. Related to unfavourable prognosis
27. T-lymphocyte requirement activity by Trypanosoma brucei
28. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo
29. Modulation of endothelial haemostatic properties by tumour necrosis factor
30. Interleukin-1 induces endothelial procoagulant activity while suppressing cell surface anticoagulant activity
31. Interleukin-1 and lipopolysacchande induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells
32. Interleukin-1 induces endothelial synthesis of plasminogen activator inhibitor
33. Tumor necrosis factor induces tissue factor-like activity in human leukaemia cell line U937 and peripheral blood monocytes
34. New roles for the endothelium in inflammation and immunity
35. Chronic inflammatory bowel disease, deep venous thrombosis and antithrombin activity
36. Deep venous thrombosis inflammatory bowel disease and protein S deficiency
37. Plasminogen activators in the intestine of patients with inflammatory bowel disease
38. Haemostasis in Crohn's disease low factor XIII levels in active disease
39. Immunocytochemical studies in ulcerative colitis and regional ileitis
40. Interleukin-1 in inflammatory bowel disease
41. Interleukin-1 in Crohn's disease
42. Dexamethasone inhibition of interleukin-1 beta production by human monocytes
43. Glucocorticoids inhibit the generation of leukocyte procoagulant (tissue factor) activity
44. Peptide regulatory factors cachectin/tumour necrosis factor
45. Secretory products of macrophages